Verona Pharma
VRNA
$13.00
Share price
-2.69%
Change (1 day)
-33.09%
Change (1 year)
Categories
Verona Pharma (VRNA) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Verona Pharma's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Verona Pharma - Cash on Hand chart (from 2020 to 2020)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | 19.29% |
| 2022-12-31 | $0.22 B | 53.54% |
| 2021-12-31 | $0.14 B | -21.07% |
| 2020-12-31 | $0.18 B | 251.3% |
| 2019-12-31 | $53.51 M | -48.65% |
| 2018-12-31 | $0.10 B | -28.91% |
| 2017-12-31 | $0.14 B | 141.85% |
| 2016-12-31 | $60.61 M | 683.41% |
| 2015-12-31 | $7.73 M | -67.97% |
| 2014-12-31 | $24.15 M | 1371.04% |
| 2013-12-31 | $1.64 M | -34.56% |
| 2012-12-31 | $2.5 M | -58.75% |
| 2011-12-31 | $6.08 M | 27.49% |
| 2010-12-31 | $4.77 M | -35.55% |
| 2009-12-31 | $7.4 M | 40.54% |
| 2008-12-31 | $5.26 M | 6.82% |
| 2007-12-31 | $4.93 M | -45.76% |
| 2006-12-31 | $9.09 M | 213.04% |
| 2005-12-31 | $2.9 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.95% | Bahamas |
 NRC Health
NRC | $6.65 M | -97.55% | 🇺🇸 USA |